CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Corticosteroids - topical (skin), nose, and eyes - Management
Basis for recommendation
These recommendations are based on published expert opinion [Coulson, 1996; MeReC, 1999; Menter et al, 2009].
- The choice of formulation depends on the condition being treated, its severity and location, and the person's preference [Coulson, 1996; Menter et al, 2009].
- Ointments are preferred for dry, lichenified, or scaly conditions. They have a more prolonged emollient effect and tend to increase the potency of the corticosteroid. They are also less likely to cause irritation as they are usually preservative-free [BNF 59, 2010].
- Tapes — occlusive polythene or hydrocolloid dressings increase the absorption of the steroid, and increase the risk of adverse effects. They should only be used under supervision for a short period of time, and for areas of very thick skin [BNF 59, 2010].
- The description of the formulations is from a textbook [Warner and Camisa, 2001; Wolverton, 2001].
© NHS Institute for Innovation and Improvement